Form 4 for ENTX Entera Bio Ltd.
Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001178913-25-000159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-17 | 2025-01-15 | ENTX | Taitel Haya | Dir | A - Grant | $0.00 | +6,922 | 64.7K | +12% | $0 |
| D | 2025-01-17 | 2025-01-15 | ENTX | Taitel Haya | Dir | A - Grant | $0.00 | +28.5K | 28.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value NIS 0.0000769 per share | 2025-01-15 | A | A | 6,922 | $0.00 | 64,650 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-01-15 | A | A | 28,509 | $0.00 | 28,509 | D | $2.28 · — to 2035-01-15 | 28,509 Ordinary Shares, par value NIS 0.0000769 per share | (F2) These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2025. |